Ionis Pharmaceuticals Inc
IONS· Nasdaq
Released Nov 9, 2022, during market hours
10-Q filed Nov 9, 2022, 40 days after period end · 0000874015-22-000168
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $159.77M | $133.09M | $160.08M | $167.89M |
| Net Income | -$46.99M | -$82.47M | -$24.47M | $26.16M |
| EPS Diluted |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.33 |
| -$0.58 |
| -$0.18 |
| $0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.